← Back

Wire · opportunities

Medera Partners with IQVIA to Accelerate Cardiac Gene Therapies and Human-Based Drug ...

Published

5 August 2026

Topic

opportunities

Sectors

Biotech

Source

Read at citybiz.co

Verified

Fusion42 · 30 August 2026 · Fusion42 review

Medera has partnered with IQVIA to enhance and accelerate the development of cardiac gene therapies and human-based drug discovery platforms, aiming to leverage IQVIA's data analytics and technology expertise.

This Wire brief sits within Fusion42's coverage of Biotech, and 2 sources have reported it.

◆ The Wire takeaway

You have a new route to speed cardiac gene therapies using IQVIA's data and tech platforms. This partnership lets you shorten your discovery timelines and boost the drug development scale without building all tech yourself.

Coverage

2 sources · 5 Aug 2026

Related on Wire

Topics

Biotechgene-therapycardiac-healthdrug-discoverybiotech-partnershippharma-tech